New Supplement Found to Trigger Self-Destruction in Prostate Cancer Cells
Researchers at Cold Spring Harbor Laboratory have discovered that menadione, a vitamin K precursor, can slow prostate cancer progression in mice by disrupting cancer cells' recycling processes, causing them to burst. This finding offers potential new treatment avenues for resistant prostate cancer and myotubular myopathy, a rare muscle condition in infants. The study suggests that menadione's pro-oxidant properties could be effective where antioxidant treatments have failed, providing hope for improved quality of life and extended survival.
